Pancreatic tumors in multiple endocrine neoplasia type 1: Clinical presentation and surgical treatment
The DOI matches its Crossref record.
Abstract
Among 33 patients with endocrine pancreatic tumors due to multiple endocrine neoplasia type 1 (MEN‐1), 19 (58%) patients had hypergastrinemia, 7 (21%) patients had hyperinsulinism, and 7 (21%) patients had clinically non‐functioning lesions. At least one gross tumor was found in all patients undergoing pancreatic surgery, including those with negative localization studies prior to operation. The patients also had additional macroscopic tumors as well as numerous microadenomas, and the lesions frequently were positive for immunostaining with multiple hormones, mainly pancreatic polypeptide, insulin, glucagon, and somatostatin. Duodenal endocrine lesions were found in 4 of 5 investigated patients and stained with gastrin and somatostatin antibodies. Distal, mainly subtotal pancreatic resection, was performed in 18 patients, eventually combined with caput tumor enucleation or duodenotomy, while a few patients underwent only tumor enucleation or a Whipple procedure. The long‐erm outcome of operation was most favorable in patients with hyperinsulinism; only 1 patient had clinical recurrence. Patients with hypergastrinemia experienced only transitory lowering of serum gastrin values after pancreatic surgery and 47% of them had or developed metastases. Such tumor spread was seen in 57% of the patients with non‐functioning lesions. Nine patients died from progressive tumor disease during follow‐up. Consistent with previous studies, we found that surgery is indicated in MEN‐1 patients with hyperinsulinism even if a lesion is not visualized by radiology. In addition, these indications should be extended to also include patients with only biochemical markers of disease, including elevations of gastrin, as these indicate the presence of gross tumors. This strategy should be applied especially in patients with aggressive family histories to possibly reduce the risk of malignant tumor progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The diagnosis and medical management of advanced neuroendocrine tumors.
Kaltsas, G. A., Besser, G. M., & Grossman, A. B. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0014 · Cited by 674
Well-Differentiated Pancreatic Nonfunctioning Tumors/Carcinoma
Falconi, M., Plöckinger, U., Kwekkeboom, D. J., Manfredi, R., Körner, M., Kvols, L., Pape, U. F., Ricke, J., Goretzki, P. E., Wildi, S., et al. (2006) · Neuroendocrinology · doi:10.1159/000098012 · Cited by 257
Self-citationNeuroendocrine Tumors of the Pancreas
Ehehalt, F., Saeger, H. D., Schmidt, C. M., & Grützmann, R. (2009) · The Oncologist · doi:10.1634/theoncologist.2008-0259 · Cited by 255
Innovative imaging of insulinoma: the end of sampling? A review
Christ, E., Antwi, K., Fani, M., & Wild, D. (2020) · Endocrine-Related Cancer · doi:10.1530/erc-19-0476 · Cited by 78
Metadata
- Authors
- Grama, D., Skogseid, B., Wilander, E., Eriksson, B., Mårtensson, H., Cedermark, B., Ahrén, B., Kristofferson, A., Öberg, K., Rastad, J., & Åkerström, G.
- Venue
- World Journal of Surgery
- Publisher
- Wiley
- Published
- 1992-07
- Volume
- 16
- Issue
- 4
- Pages
- 611-618
- ISSN
- 0364-2313 (ISSN-L)
- 1432-2323
- OpenAlex
- W2093078744
- Cited by
- 104
- References
- 0
- FWCI
- 3.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.